News and Events
12/2021: UGA Biopharma enters partnership with Tosoh Bioscience
UGA
Biopharma GmbH has entered a partnership with US-based Tosoh Bioscience LLC to
exchange knowledge on upstream and downstream bioprocessing (USP/DSP) ...read more
10/2021: UGA Biopharma to showcase their Cell line development platform at BIO-Europe Digital
UGA
Biopharma GmbH, the leading-edge contract development and research organization
for biologics and biosimilars, will once again be a high-profile ...read more
05/2021: Tcell Tolerance GmbH assigned UGA Biopharma to develop a highly efficient CHO cell line and bioprocess
UGA
Biopharma is developing a new and more efficient CHO-DG44 cell line for
German-based startup ...read more
04/2021: Scale-Up of a Biosimilar Production Process
Eppendorf
and UGA Biopharma GmbH recently published the application note: “Scale-Up of a
Biosimilar Production Process with CHO Cells from Small to ...read more
03/2021: UGA Biopharma at BIO-Europe Spring 2021
UGA Biopharma GmbH will return to the annual BIO-Europe Spring biotech industry partnering conference, hosted in virtual format for 2021.UGA Biopharma, which has a ...read more
03/2021: Russian developer Mabscale in-licensed UGA Biopharma´s biosimilar cell lines
UGA has
out-licensed two of its innovative ready-to-use biosimilar cell lines to
Russia-based ...read more
12/2020: UGA Biopharma wishes Merry Christmas and a Happy New Year!
Traditionally
the Cell line development UGA family gathers all together to celebrate
Christmas. Due to ...read more
10/2020: UGA Biopharma presents efficient development of stable high titer cell lines at BIO Europe DIGITAL convention 2020
UGA
Biopharma GmbH will present its latest high-performance stable CHO cell lines
for high titer production of ...read more
09/2020: UGA Biopharma GmbH participates at the virtual CPhI Festival of Pharma 2020
UGA
Biopharma GmbH will participate in the virtual CPhI Festival of Pharma 2020 over
eleven days in October. The CPhI Festival will take the form of a ...read more
09/2020: FcR affinity chromatography - a new approach to assess glycan profiles
TOSOH
Bioscience and UGA Biopharma did cooperate on a project regarding FcR Affinity
chromatography. The outcome of this project is described in the ...read more
09/2020: Case study with Evidentic
Evidentic
and UGA Biopharma collaborated for a case study which was recently published on
the website of Evidentic, “Aliquots: A New Solution to the ...read more
09/2020: New method for EPO purification patented by UGA Biopharma
We have developed
a newly patented method for the purification of the evolutionarily conserved
hormone Erythropoietin (EPO) and its ...read more
07/2020: UGA Biopharma to debut at digital Bioprocessing Summit Europe
UGA
Biopharma GmbH will make its debut at the upcoming annual Bioprocessing Summit
Europe conference, now repurposed as a virtual online event in response ...read more
06/2020: UGA Biopharma at the BIO Digital 2020 meeting
We will take
part at the annual BIO International Convention USA 2020 for the first time, which
was re-branded BIO Digital because of the coronavirus ...read more
04/2020: UGA Biopharma´s high-speed cell line development workflow
The UGA
Biopharma GmbH high-speed workflow was established as an improved cell line
development workflow that guarantees CHO cell line development on a ...read more
03/2020: COVID-19 statement from UGA Biopharma GmbH
Dear valued
customer, partner and friends of UGA Biopharma GmbH,
as all of
us, we also closely ...read more
03/2020: Meet UGA Biopharma GmbH at BIO-Europe Spring virtual conference
UGA Biopharma GmbH will present its value-added mammalian cell line development services at the upcoming annual BIO-Europe Spring® biotech industry partnering conference, now to be hosted ...read more
11/2019: Meet our CEO at the CPhI in Frankfurt and Bio-Europe in Hamburg
Do not miss the opportunity to meet Dr. Lars Kober, CEO of UGA Biopharma GmbH at the CPhI in Frankfurt from November 5-8, 2019 as well as at ...read more
09/2019: UGA Biopharma presented the benefits of First CHOice® Media
September 18, 2019: Sarah Herrman, head of the Technology Development Group, presented her data at the conference „New and Emerging Technologies – Biotech meets Medicine“ in Potsdam-Golm. ...read more
05/2019: High Ranking Delegation from China
UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes ...read more
05/2019: ESACT Meeting in Copenhagen
On behalf of all UGA team members, we would like to thank all our customers and partners for their valuable and long-standing ...read more
12/2017: Four projects successfully completed in Q4
Four biosimilar development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now! ...read more
11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA.
...read more
10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that
...read more
09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this ...read more
08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing ...read more
07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging ...read more
05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services"...read more
04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made ...read more
03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time ...read more
Contact
UGA Biopharma GmbHNeuendorfstraße 20a
16761 Hennigsdorf
Germany
E-mail: info@ugabiopharma.com
Phone: +49(0)3302 / 2024900